Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients have?
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients has 18 citations in the OpenAlex counts ScholarIQ stores.
When was Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients published?
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients has 2021 year in the ScholarIQ index.
What is the open-access status of Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients?
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients has gold oa status in the ScholarIQ index.
What is the DOI of Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients?
The DOI for Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients is on the source record.
What is the PMID of Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients?
The PMID for Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients is on the source record.
What is the OpenAlex record for Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients?
The OpenAlex for Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients is on the source record.